Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
5.82M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
126K
-
Shares change
-
+114K
-
Total reported value, excl. options
-
$87.5K
-
Value change
-
+$79.5K
-
Number of buys
-
8
-
Price
-
$0.69
Significant Holders of NovaBay Pharmaceuticals, Inc. - Common Stock, par value $0.01 per share (NBY) as of Q3 2024
12 filings reported holding NBY - NovaBay Pharmaceuticals, Inc. - Common Stock, par value $0.01 per share as of Q3 2024.
NovaBay Pharmaceuticals, Inc. - Common Stock, par value $0.01 per share (NBY) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 126K shares
of 5.82M outstanding shares and own 2.17% of the company stock.
Largest 10 shareholders include C2C Wealth Management, LLC (42.9K shares), GEODE CAPITAL MANAGEMENT, LLC (26.3K shares), UBS Group AG (21.1K shares), Virtu Financial LLC (19.6K shares), Warberg Asset Management LLC (10K shares), Tower Research Capital LLC (TRC) (5.48K shares), MORGAN STANLEY (503 shares), BANK OF AMERICA CORP /DE/ (42 shares), NVWM, LLC (3 shares), and Blue Trust, Inc. (2 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.